Nike (NYSE: NKE) shares are declining premarket Friday after the company reported its earnings, lowering its fiscal 2022 outlook. Nike shares are down 4.8% at $151.90 pre

Shares of Seeing Machines Limited (LON: SEE) surged 10.6% after unveiling its 8th generation Occula® Neural Processing Unit (NPU) yesterday after the US markets closed, which is likely the main reason behind today’s rally. From a technical perspec

Avon Protection (LON: AVON) said Friday that the US Defense Logistics Agency (DLA) has exercised the first of the two one-year extension options under the DLA Enhanced Small Arms Protective Inserts body armor contra

Shares of Argo Blockchain PLC (LON: ARB) fell 14.1% in the London market after the debut of its American depository shares (ADS) on the Nasdaq Global Select Market yesterday. The company priced each ADS at $15 representing 10 of its London-listed

Shares of Symphony Environmental Technologies plc (LON: SYM) gapped up 7.74% after announcing that it had raised £750,000 via a share subscription with the shares sold at a premium. The company noted that Vincel Investment Holdings Limited bought

Software and services firm Gresham Technologies (LON: GHT) has seen its shares gain on Friday after it confirmed its largest customer has signed contracts that renew and materially increase its investment in the com

Shares of Scirocco Energy PLC (LON: SCIR) rallied 6.45% after revealing that the operator for its Ruvuma joint venture project had awarded the contract for seismic mapping for the Chikumbi-1 well at a significant discount. Investors cheered the fa

Microsaic Systems (MSYS) shares are gaining on Friday after it announced the signing of an agreement with Jiangsu Henzhihe Technologies (HZH). Microsaic, a developer of p

Shares of Quadrise Fuels International Plc (LON: QFI) rallied 21.8% after conducting a series of tests for Tomco Energy’s Greenfield project in Utah and presenting positive results to the client. According to Tomco Energy, the tests carried out by

Shares of Scottish Mortgage Investment Trust PLC (LON: SMT) just broke to new all-time highs reaching a high of 1458p earlier today. What’s next for the fund? The investment fund’s bet on growth stocks continues to pay off as the cyclical rotation

Four Seasons Edu (Cayman) Inc ADR (NYSE: FEDU) stock price soared 69.1% after its board authorised a $15 million share repurchase program. The company, which provides after-school education services, is based in Shanghai, China. The share repurcha

Eargo Inc (NASDAQ: EAR) stock plunged 61.6% after revealing that it was being investigated by the U.S. Department of Justice regarding insurance claims filed on behalf of its customers. The hearing aids company was quickly downgraded by analysts f

Shares of Transcode Therapeutics Inc (NASDAQ: RNAZ) gapped 62.8% higher after publishing positive preclinical data supporting the therapeutic potential of its lead drug candidate, TTX-MC138, which targets metastatic cancers. The imaging study publ

MEDIROM Healthcare Technologies (Nasdaq: MRM) shares are rallying premarket on news that it has entered into a deal to acquire ZACC Kabushiki Kaisha. ZACC is a Japanese h

Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHC), a special purpose acquisition company, has seen its shares surge premarket after announcing that its stockholders voted to approve the business combinatio

Rockhopper Exploration (LON: RKH) shares plunged on Thursday after Harbour Energy announced it would not proceed with the Sea Lion project.  The Sea Lion project, with in

Union Jack Oil (LON: UJO) shares are down Thursday after announcing it has raised £3 million from a placing of 13.6 million new ordinary shares. The UK-focused onshore hy

Shares of digital performance publisher XLMedia (LON: XLM) fell Thursday after the company reported a pretax loss for the six months ended 30 June 2021. The AIM-quoted fi

Workhorse Group (NASDAQ: WKHS) shares plunged Wednesday after the company decided to suspend deliveries of C-1000 vehicles and recall 41 cars it had already delivered. Wo

Shares of Cassava Sciences (NASDAQ: SAVA) are rallying premarket after the company announced top-line clinical data from a pre-planned interim analysis of an ongoing open-label study with its drug candidate simufila